icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study

Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study

icon 2025-03-16
داعم الدراسة
King Abdullah International Medical Research Center’s (KAIMRC)
دواء الدراسة
Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine
رقم بروتوكول الدراسة
RJ19/119/J
حالة الدراسة
Ongoing
موقع الدراسة
King Abdullah Medical Complex (Jeddah)
مرحلة الدراسة
2

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 16/03/2025 at 02:33 PM Saudi Arabia time